MedPath

Comparison of Bromelain and Serrati peptidase as an add on therapy with Ibuprofen on post operative sequelae following surgical removal of impacted mandibular third molar - A Double blind Randomized Clinical Trial

Not Applicable
Conditions
Health Condition 1: K011- Impacted teeth
Registration Number
CTRI/2023/05/052489
Lead Sponsor
Dr B Logeshwaran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA I & II

All impacted mandibular third molars requiring surgical removal

Exclusion Criteria

Acute infection

Patients on NSAIDS, Bromelain and Serratiopeptidase

Patients with bleeding disorders, Pregnancy and Lactation, Immunocompromised, Mentally Challenged,Patients with GERD and systemic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PainTimepoint: 1Day, 3Day , 7Day
Secondary Outcome Measures
NameTimeMethod
Trismus <br/ ><br>SwellingTimepoint: 1Day, 3Day , 7Day
© Copyright 2025. All Rights Reserved by MedPath